Skip to main content
PMC home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1995;93:623–683.

Ocular manifestations of HIV infection.

D A Jabs 1
PMCID: PMC1312074  PMID: 8719695

Abstract

OBJECTIVE: To evaluate the frequency of ocular complications and the clinical outcomes of these complications in patients with various stages of HIV infection. METHODS: Retrospective review of all HIV-infected patients seen in an AIDS ophthalmology clinic from November 1983 through December 31, 1992. RESULTS: Eleven-hundred sixty-three patients were seen for ophthalmologic evaluation. Of these, 781 had the acquired immune deficiency syndrome (AIDS), 226 had symptomatic HIV infection (AIDs-related complex [ARC]), and 156 had asymptomatic HIV infection. Non-infectious HIV retinopathy was the most common ocular complication, affecting 50% of the patients with AIDS, 34% of the patients with ARC, and 3% of the patients with asymptomatic HIV infection. Cytomegalovirus (CMV) retinitis was the most common opportunistic ocular infection, affecting 37% of the patients with AIDS. Other opportunistic ocular infections, including ocular toxoplasmosis, varicella zoster virus retinitis, and Pneumocystis choroidopathy were all much less common, each occurring in < or = 1% of the patients with AIDS. Treatment of CMV retinitis with either foscarnet or ganciclovir was successful in initially controlling the retinitis. However, relapse represented a significant problem and required frequent re-inductions. As a consequence of the retinal damage associated with relapse, loss of visual acuity occurred. The median time to a visual acuity of 20/200 or worse for all eyes with CMV retinitis was 13.4 months, and the median time to a visual acuity of 20/200 or worse in the better eye was 21.1 months. At last follow-up, 75% of the patients had a final visual acuity of 20/40 or better in at least one eye. Retinal detachments were a frequent ophthalmologic complication of CMV retinitis with a cumulative probability of a retinal detachment in at least one eye of 57% at 12 months after the diagnosis of CMV retinitis. Herpes zoster ophthalmicus developed in 3% of the overall series and was seen in all stages of HIV infection. Fifty-six percent of the cases of ocular toxoplasmosis had simultaneous toxoplasmic cerebritis. Ocular toxoplasmosis responded to standard anti-microbial therapy. Varicella zoster virus retinitis, when manifested by the acute retinal necrosis (ARN) syndrome, responded to intravenous acyclovir therapy. Conversely, in a limited number of patients with the progressive outer retinal necrosis syndrome, the disease responded poorly to intravenous acyclovir therapy, but appeared to respond to combination foscarnet and acyclovir therapy. Neuro-ophthalmic lesions were present in 6% of the patients with AIDS. The most common cause of a neuro-ophthalmic lesion was cryptococcal meningitis, and 25% of the patients with cryptococcal meningitis developed a neuro-ophthalmic complication. CONCLUSIONS: Ocular manifestations are common in patients with AIDS. CMV retinitis represented a major vision-threatening problem in these patients. While available therapy was successful in initially controlling the retinitis, the phenomenon of relapse resulted in some degree of long-term visual loss. Preservation of the patient's visual acuity in at least one eye was generally successful. Other opportunistic ocular infections were substantially less common than CMV retinitis but require aggressive therapy.

Full text

PDF
623

Images in this article

627FIGURE 1
on p.627
628FIGURE 2
on p.628
628FIGURE 3
on p.628
629FIGURE 4
on p.629
630FIGURE 5
on p.630
631FIGURE 6
on p.631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand R., Nightingale S. D., Fish R. H., Smith T. J., Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993 Feb;111(2):223–227. doi: 10.1001/archopht.1993.01090020077027. [DOI] [PubMed] [Google Scholar]
  2. Antle C. M., White V. A., Horsman D. E., Rootman J. Large cell orbital lymphoma in a patient with acquired immune deficiency syndrome. Case report and review. Ophthalmology. 1990 Nov;97(11):1494–1498. doi: 10.1016/s0161-6420(90)32398-9. [DOI] [PubMed] [Google Scholar]
  3. Aristimuño B., Nirankari V. S., Hemady R. K., Rodrigues M. M. Spontaneous ulcerative keratitis in immunocompromised patients. Am J Ophthalmol. 1993 Feb 15;115(2):202–208. doi: 10.1016/s0002-9394(14)73924-8. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. F., Bloch A. B., Davidson P. T., Snider D. E., Jr Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991 Jun 6;324(23):1644–1650. doi: 10.1056/NEJM199106063242307. [DOI] [PubMed] [Google Scholar]
  5. Becerra L. I., Ksiazek S. M., Savino P. J., Marcus D. K., Buckley R. M., Sergott R. C., Bosley T. M. Syphilitic uveitis in human immunodeficiency virus-infected and noninfected patients. Ophthalmology. 1989 Dec;96(12):1727–1730. doi: 10.1016/s0161-6420(89)32657-1. [DOI] [PubMed] [Google Scholar]
  6. Berenguer J., Moreno S., Laguna F., Vicente T., Adrados M., Ortega A., González-LaHoz J., Bouza E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992 Mar 5;326(10):668–672. doi: 10.1056/NEJM199203053261004. [DOI] [PubMed] [Google Scholar]
  7. Blodi B. A., Johnson M. W., McLeish W. M., Gass J. D. Presumed choroidal tuberculosis in a human immunodeficiency virus infected host. Am J Ophthalmol. 1989 Nov 15;108(5):605–607. doi: 10.1016/0002-9394(89)90448-0. [DOI] [PubMed] [Google Scholar]
  8. Bloom J. N., Palestine A. G. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988 Dec 15;109(12):963–969. doi: 10.7326/0003-4819-109-12-963. [DOI] [PubMed] [Google Scholar]
  9. Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J. A., Tilles J. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1991 Feb 28;324(9):580–584. doi: 10.1056/NEJM199102283240902. [DOI] [PubMed] [Google Scholar]
  10. Buhles W. C., Jr, Mastre B. J., Tinker A. J., Strand V., Koretz S. H. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S495–S506. doi: 10.1093/clinids/10.supplement_3.s495. [DOI] [PubMed] [Google Scholar]
  11. Cantrill H. L., Henry K., Melroe N. H., Knobloch W. H., Ramsay R. C., Balfour H. H., Jr Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology. 1989 Mar;96(3):367–374. doi: 10.1016/s0161-6420(89)32900-9. [DOI] [PubMed] [Google Scholar]
  12. Cantwell M. F., Snider D. E., Jr, Cauthen G. M., Onorato I. M. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994 Aug 17;272(7):535–539. [PubMed] [Google Scholar]
  13. Carr A., Tindall B., Brew B. J., Marriott D. J., Harkness J. L., Penny R., Cooper D. A. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med. 1992 Jul 15;117(2):106–111. doi: 10.7326/0003-4819-117-2-106. [DOI] [PubMed] [Google Scholar]
  14. Carter J. B., Hamill R. J., Matoba A. Y. Bilateral syphilitic optic neuritis in a patient with a positive test for HIV. Case report. Arch Ophthalmol. 1987 Nov;105(11):1485–1486. doi: 10.1001/archopht.1987.01060110031015. [DOI] [PubMed] [Google Scholar]
  15. Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
  16. Cobo L. M., Foulks G. N., Liesegang T., Lass J., Sutphin J. E., Wilhelmus K., Jones D. B., Chapman S., Segreti A. C., King D. H. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986 Jun;93(6):763–770. doi: 10.1016/s0161-6420(86)33678-9. [DOI] [PubMed] [Google Scholar]
  17. Cochereau-Massin I., LeHoang P., Lautier-Frau M., Zerdoun E., Zazoun L., Robinet M., Marcel P., Girard B., Katlama C., Leport C. Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol. 1992 Aug 15;114(2):130–135. doi: 10.1016/s0002-9394(14)73975-3. [DOI] [PubMed] [Google Scholar]
  18. Cochereau-Massin I., Lehoang P., Lautier-Frau M., Zazoun L., Marcel P., Robinet M., Matheron S., Katlama C., Gharakhanian S., Rozenbaum W. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1991 Sep;98(9):1348–1355. doi: 10.1016/s0161-6420(91)32135-3. [DOI] [PubMed] [Google Scholar]
  19. Cohen D. B., Glasgow B. J. Bilateral optic nerve cryptococcosis in sudden blindness in patients with acquired immune deficiency syndrome. Ophthalmology. 1993 Nov;100(11):1689–1694. doi: 10.1016/s0161-6420(93)31416-8. [DOI] [PubMed] [Google Scholar]
  20. Cole E. L., Meisler D. M., Calabrese L. H., Holland G. N., Mondino B. J., Conant M. A. Herpes zoster ophthalmicus and acquired immune deficiency syndrome. Arch Ophthalmol. 1984 Jul;102(7):1027–1029. doi: 10.1001/archopht.1984.01040030829026. [DOI] [PubMed] [Google Scholar]
  21. Collier A. C., Meyers J. D., Corey L., Murphy V. L., Roberts P. L., Handsfield H. H. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med. 1987 Mar 23;82(3 Spec No):593–601. doi: 10.1016/0002-9343(87)90105-7. [DOI] [PubMed] [Google Scholar]
  22. Coskuncan N. M., Jabs D. A., Dunn J. P., Haller J. A., Green W. R., Vogelsang G. B., Santos G. W. The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol. 1994 Mar;112(3):372–379. doi: 10.1001/archopht.1994.01090150102031. [DOI] [PubMed] [Google Scholar]
  23. Croxatto J. O., Mestre C., Puente S., Gonzalez G. Nonreactive tuberculosis in a patient with acquired immune deficiency syndrome. Am J Ophthalmol. 1986 Nov 15;102(5):659–660. doi: 10.1016/0002-9394(86)90543-x. [DOI] [PubMed] [Google Scholar]
  24. Currie J., Benson E., Ramsden B., Perdices M., Cooper D. Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex. Arch Neurol. 1988 Sep;45(9):949–953. doi: 10.1001/archneur.1988.00520330027006. [DOI] [PubMed] [Google Scholar]
  25. Dannemann B., McCutchan J. A., Israelski D., Antoniskis D., Leport C., Luft B., Nussbaum J., Clumeck N., Morlat P., Chiu J. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992 Jan 1;116(1):33–43. doi: 10.7326/0003-4819-116-1-33. [DOI] [PubMed] [Google Scholar]
  26. Davis J. L., Nussenblatt R. B., Bachman D. M., Chan C. C., Palestine A. G. Endogenous bacterial retinitis in AIDS. Am J Ophthalmol. 1989 Jun 15;107(6):613–623. doi: 10.1016/0002-9394(89)90258-4. [DOI] [PubMed] [Google Scholar]
  27. Drew W. L., Miner R. C., Busch D. F., Follansbee S. E., Gullett J., Mehalko S. G., Gordon S. M., Owen W. F., Jr, Matthews T. R., Buhles W. C. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991 Apr;163(4):716–719. doi: 10.1093/infdis/163.4.716. [DOI] [PubMed] [Google Scholar]
  28. Dugel P. U., Gill P. S., Frangieh G. T., Rao N. A. Ocular adnexal Kaposi's sarcoma in acquired immunodeficiency syndrome. Am J Ophthalmol. 1990 Nov 15;110(5):500–503. doi: 10.1016/s0002-9394(14)77872-9. [DOI] [PubMed] [Google Scholar]
  29. Dugel P. U., Gill P. S., Frangieh G. T., Rao N. A. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology. 1992 Jul;99(7):1127–1132. doi: 10.1016/s0161-6420(92)31841-x. [DOI] [PubMed] [Google Scholar]
  30. Dugel P. U., Liggett P. E., Lee M. B., Ziogas A., Forster D. J., Smith R. E., Rao N. A. Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991 Sep 15;112(3):235–242. doi: 10.1016/s0002-9394(14)76723-6. [DOI] [PubMed] [Google Scholar]
  31. Dugel P. U., Rao N. A., Forster D. J., Chong L. P., Frangieh G. T., Sattler F. Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am J Ophthalmol. 1990 Aug 15;110(2):113–117. doi: 10.1016/s0002-9394(14)76978-8. [DOI] [PubMed] [Google Scholar]
  32. Edlin B. R., Tokars J. I., Grieco M. H., Crawford J. T., Williams J., Sordillo E. M., Ong K. R., Kilburn J. O., Dooley S. W., Castro K. G. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jun 4;326(23):1514–1521. doi: 10.1056/NEJM199206043262302. [DOI] [PubMed] [Google Scholar]
  33. Engstrom R. E., Jr, Holland G. N., Hardy W. D., Meiselman H. J. Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol. 1990 Feb 15;109(2):153–161. doi: 10.1016/s0002-9394(14)75980-x. [DOI] [PubMed] [Google Scholar]
  34. Engstrom R. E., Jr, Holland G. N., Margolis T. P., Muccioli C., Lindley J. I., Belfort R., Jr, Holland S. P., Johnston W. H., Wolitz R. A., Kreiger A. E. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994 Sep;101(9):1488–1502. doi: 10.1016/s0161-6420(94)31142-0. [DOI] [PubMed] [Google Scholar]
  35. Eriksson B. F., Schinazi R. F. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Antimicrob Agents Chemother. 1989 May;33(5):663–669. doi: 10.1128/aac.33.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Faber D. W., Wiley C. A., Lynn G. B., Gross J. G., Freeman W. R. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2345–2353. [PubMed] [Google Scholar]
  37. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  38. Farrell P. L., Heinemann M. H., Roberts C. W., Polsky B., Gold J. W., Mamelok A. Response of human immunodeficiency virus-associated uveitis to zidovudine. Am J Ophthalmol. 1988 Jul 15;106(1):7–10. doi: 10.1016/s0002-9394(14)76379-2. [DOI] [PubMed] [Google Scholar]
  39. Fischl M. A., Daikos G. L., Uttamchandani R. B., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Oldham S. A. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992 Aug 1;117(3):184–190. doi: 10.7326/0003-4819-117-3-184. [DOI] [PubMed] [Google Scholar]
  40. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  41. Forster D. J., Dugel P. U., Frangieh G. T., Liggett P. E., Rao N. A. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1990 Oct 15;110(4):341–348. doi: 10.1016/s0002-9394(14)77012-6. [DOI] [PubMed] [Google Scholar]
  42. Freeman W. R., Chen A., Henderly D. E., Levine A. M., Luttrull J. K., Urrea P. T., Arthur J., Rasheed S., Cohen J. L., Neuberg D. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989 Mar 15;107(3):229–235. doi: 10.1016/0002-9394(89)90304-8. [DOI] [PubMed] [Google Scholar]
  43. Freeman W. R., Friedberg D. N., Berry C., Quiceno J. I., Behette M., Fullerton S. C., Munguia D. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993 Dec 15;116(6):713–720. doi: 10.1016/s0002-9394(14)73471-3. [DOI] [PubMed] [Google Scholar]
  44. Freeman W. R., Gross J. G., Labelle J., Oteken K., Katz B., Wiley C. A. Pneumocystis carinii choroidopathy. A new clinical entity. Arch Ophthalmol. 1989 Jun;107(6):863–867. doi: 10.1001/archopht.1989.01070010885036. [DOI] [PubMed] [Google Scholar]
  45. Freeman W. R., Henderly D. E., Wan W. L., Causey D., Trousdale M., Green R. L., Rao N. A. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1987 Apr 15;103(4):527–536. doi: 10.1016/s0002-9394(14)74276-x. [DOI] [PubMed] [Google Scholar]
  46. Freeman W. R., Lerner C. W., Mines J. A., Lash R. S., Nadel A. J., Starr M. B., Tapper M. L. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol. 1984 Feb;97(2):133–142. doi: 10.1016/s0002-9394(14)76082-9. [DOI] [PubMed] [Google Scholar]
  47. Freeman W. R., Quiceno J. I., Crapotta J. A., Listhaus A., Munguia D., Aguilar M. F. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992 Mar;99(3):466–474. doi: 10.1016/s0161-6420(92)31976-1. [DOI] [PubMed] [Google Scholar]
  48. Friedberg D. N., Stenson S. M., Orenstein J. M., Tierno P. M., Charles N. C. Microsporidial keratoconjunctivitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1990 Apr;108(4):504–508. doi: 10.1001/archopht.1990.01070060052047. [DOI] [PubMed] [Google Scholar]
  49. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  50. Gallant J. E., Moore R. D., Chaisson R. E. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994 Jun 1;120(11):932–944. doi: 10.7326/0003-4819-120-11-199406010-00006. [DOI] [PubMed] [Google Scholar]
  51. Gallant J. E., Moore R. D., Richman D. D., Keruly J., Chaisson R. E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis. 1992 Dec;166(6):1223–1227. doi: 10.1093/infdis/166.6.1223. [DOI] [PubMed] [Google Scholar]
  52. Geier S. A., Hammel G., Bogner J. R., Kronawitter U., Berninger T., Goebel F. D. HIV-related ocular microangiopathic syndrome and color contrast sensitivity. Invest Ophthalmol Vis Sci. 1994 Jun;35(7):3011–3021. [PubMed] [Google Scholar]
  53. Ghabrial R., Quivey J. M., Dunn J. P., Jr, Char D. H. Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva. Arch Ophthalmol. 1992 Oct;110(10):1423–1426. doi: 10.1001/archopht.1992.01080220085027. [DOI] [PubMed] [Google Scholar]
  54. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. doi: 10.1056/NEJM198112103052401. [DOI] [PubMed] [Google Scholar]
  55. Gross J. G., Bozzette S. A., Mathews W. C., Spector S. A., Abramson I. S., McCutchan J. A., Mendez T., Munguia D., Freeman W. R. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990 May;97(5):681–686. doi: 10.1016/s0161-6420(90)32552-6. [DOI] [PubMed] [Google Scholar]
  56. Gupta S., Licorish K. Circulating immune complexes in AIDS. N Engl J Med. 1984 Jun 7;310(23):1530–1531. doi: 10.1056/NEJM198406073102312. [DOI] [PubMed] [Google Scholar]
  57. Hamed L. M., Schatz N. J., Galetta S. L. Brainstem ocular motility defects and AIDS. Am J Ophthalmol. 1988 Oct 15;106(4):437–442. doi: 10.1016/0002-9394(88)90880-x. [DOI] [PubMed] [Google Scholar]
  58. Harb G. E., Bacchetti P., Jacobson M. A. Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet. AIDS. 1991 Aug;5(8):959–965. doi: 10.1097/00002030-199108000-00006. [DOI] [PubMed] [Google Scholar]
  59. Hardy W. D., Feinberg J., Finkelstein D. M., Power M. E., He W., Kaczka C., Frame P. T., Holmes M., Waskin H., Fass R. J. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992 Dec 24;327(26):1842–1848. doi: 10.1056/NEJM199212243272604. [DOI] [PubMed] [Google Scholar]
  60. Heinemann M. H. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1989 Dec;107(12):1767–1772. doi: 10.1001/archopht.1989.01070020849025. [DOI] [PubMed] [Google Scholar]
  61. Henderly D. E., Freeman W. R., Causey D. M., Rao N. A. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology. 1987 Apr;94(4):425–434. doi: 10.1016/s0161-6420(87)33454-2. [DOI] [PubMed] [Google Scholar]
  62. Hirschel B., Lazzarin A., Chopard P., Opravil M., Furrer H. J., Rüttimann S., Vernazza P., Chave J. P., Ancarani F., Gabriel V. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med. 1991 Apr 18;324(16):1079–1083. doi: 10.1056/NEJM199104183241602. [DOI] [PubMed] [Google Scholar]
  63. Hirst L. W., Jabs D. A., Tutschka P. J., Green W. R., Santos G. W. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983 Apr;101(4):580–584. doi: 10.1001/archopht.1983.01040010580010. [DOI] [PubMed] [Google Scholar]
  64. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  65. Hochster H., Dieterich D., Bozzette S., Reichman R. C., Connor J. D., Liebes L., Sonke R. L., Spector S. A., Valentine F., Pettinelli C. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. Ann Intern Med. 1990 Jul 15;113(2):111–117. doi: 10.7326/0003-4819-113-2-111. [DOI] [PubMed] [Google Scholar]
  66. Holland G. N., Buhles W. C., Jr, Mastre B., Kaplan H. J. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989 Dec;107(12):1759–1766. doi: 10.1001/archopht.1989.01070020841024. [DOI] [PubMed] [Google Scholar]
  67. Holland G. N., Engstrom R. E., Jr, Glasgow B. J., Berger B. B., Daniels S. A., Sidikaro Y., Harmon J. A., Fischer D. H., Boyer D. S., Rao N. A. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988 Dec 15;106(6):653–667. doi: 10.1016/0002-9394(88)90697-6. [DOI] [PubMed] [Google Scholar]
  68. Holland G. N., Gottlieb M. S., Yee R. D., Schanker H. M., Pettit T. H. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol. 1982 Apr;93(4):393–402. doi: 10.1016/0002-9394(82)90127-1. [DOI] [PubMed] [Google Scholar]
  69. Holland G. N., Pepose J. S., Pettit T. H., Gottlieb M. S., Yee R. D., Foos R. Y. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology. 1983 Aug;90(8):859–873. doi: 10.1016/s0161-6420(83)80009-8. [DOI] [PubMed] [Google Scholar]
  70. Holland G. N., Shuler J. D. Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol. 1992 Oct;110(10):1435–1442. doi: 10.1001/archopht.1992.01080220097029. [DOI] [PubMed] [Google Scholar]
  71. Holland G. N., Sidikaro Y., Kreiger A. E., Hardy D., Sakamoto M. J., Frenkel L. M., Winston D. J., Gottlieb M. S., Bryson Y. J., Champlin R. E. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology. 1987 Jul;94(7):815–823. doi: 10.1016/s0161-6420(87)33534-1. [DOI] [PubMed] [Google Scholar]
  72. Holland G. N., Sison R. F., Jatulis D. E., Haslop M. G., Sakamoto M. J., Wheeler N. C. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group. Ophthalmology. 1990 Feb;97(2):204–211. doi: 10.1016/s0161-6420(90)32616-7. [DOI] [PubMed] [Google Scholar]
  73. Holland G. N. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994 May 15;117(5):663–667. doi: 10.1016/s0002-9394(14)70075-3. [DOI] [PubMed] [Google Scholar]
  74. Hoover D. R., Saah A. J., Bacellar H., Phair J., Detels R., Anderson R., Kaslow R. A. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med. 1993 Dec 23;329(26):1922–1926. doi: 10.1056/NEJM199312233292604. [DOI] [PubMed] [Google Scholar]
  75. Humphry R. C., Parkin J. M., Marsh R. J. The ophthalmological features of AIDS and AIDS related disorders. Trans Ophthalmol Soc U K. 1986;105(Pt 5):505–509. [PubMed] [Google Scholar]
  76. Iseman M. D. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993 Sep 9;329(11):784–791. doi: 10.1056/NEJM199309093291108. [DOI] [PubMed] [Google Scholar]
  77. Jabs D. A., Enger C., Bartlett J. G. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jan;107(1):75–80. doi: 10.1001/archopht.1989.01070010077031. [DOI] [PubMed] [Google Scholar]
  78. Jabs D. A., Enger C., Haller J., de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991 Jun;109(6):794–799. doi: 10.1001/archopht.1991.01080060058024. [DOI] [PubMed] [Google Scholar]
  79. Jabs D. A., Green W. R., Fox R., Polk B. F., Bartlett J. G. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989 Jul;96(7):1092–1099. doi: 10.1016/s0161-6420(89)32794-1. [DOI] [PubMed] [Google Scholar]
  80. Jabs D. A., Newman C., De Bustros S., Polk B. F. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987 Jul;94(7):824–830. doi: 10.1016/s0161-6420(87)33535-3. [DOI] [PubMed] [Google Scholar]
  81. Jabs D. A., Schachat A. P., Liss R., Knox D. L., Michels R. G. Presumed varicella zoster retinitis in immunocompromised patients. Retina. 1987 Spring;7(1):9–13. [PubMed] [Google Scholar]
  82. Jacobsen M. A., van der Horst C., Causey D. M., Dehlinger M., Hafner R., Mills J. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053). J Infect Dis. 1991 Jun;163(6):1219–1222. doi: 10.1093/infdis/163.6.1219. [DOI] [PubMed] [Google Scholar]
  83. Jacobson M. A., Causey D., Polsky B., Hardy D., Chown M., Davis R., O'Donnell J. J., Kuppermann B. D., Heinemann M. H., Holland G. N. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis. 1993 Aug;168(2):444–448. doi: 10.1093/infdis/168.2.444. [DOI] [PubMed] [Google Scholar]
  84. Jacobson M. A., O'Donnell J. J., Brodie H. R., Wofsy C., Mills J. Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis. J Med Virol. 1988 Jul;25(3):339–349. doi: 10.1002/jmv.1890250311. [DOI] [PubMed] [Google Scholar]
  85. Jacobson M. A., O'Donnell J. J., Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1989 May;33(5):736–741. doi: 10.1128/aac.33.5.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Jacobson M. A., O'Donnell J. J., Porteous D., Brodie H. R., Feigal D., Mills J. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy. Q J Med. 1988 Jun;67(254):473–486. [PubMed] [Google Scholar]
  87. Katlama C., Dohin E., Caumes E., Cochereau-Massin I., Brancon C., Robinet M., Rogeaux O., Dahan R., Gentilini M. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. J Acquir Immune Defic Syndr. 1992;5 (Suppl 1):S18–S24. [PubMed] [Google Scholar]
  88. Keane J. R. Neuro-ophthalmologic signs of AIDS: 50 patients. Neurology. 1991 Jun;41(6):841–845. doi: 10.1212/wnl.41.6.841. [DOI] [PubMed] [Google Scholar]
  89. Kestelyn P., Stevens A. M., Bakkers E., Rouvroy D., Van de Perre P. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol. 1987 Nov;71(11):806–809. doi: 10.1136/bjo.71.11.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Kestelyn P., Taelman H., Bogaerts J., Kagame A., Abdel Aziz M., Batungwanayo J., Stevens A. M., Van de Perre P. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 Dec 15;116(6):721–727. doi: 10.1016/s0002-9394(14)73472-5. [DOI] [PubMed] [Google Scholar]
  91. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  92. Kong X. B., Zhu Q. Y., Ruprecht R. M., Watanabe K. A., Zeidler J. M., Gold J. W., Polsky B., Armstrong D., Chou T. C. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine. Antimicrob Agents Chemother. 1991 Oct;35(10):2003–2011. doi: 10.1128/aac.35.10.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kovacs J. A., Kovacs A. A., Polis M., Wright W. C., Gill V. J., Tuazon C. U., Gelmann E. P., Lane H. C., Longfield R., Overturf G. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Oct;103(4):533–538. doi: 10.7326/0003-4819-103-4-533. [DOI] [PubMed] [Google Scholar]
  94. Kupfer C., McCrane E. A possible cause of decreased vision in cryptococcal meningitis. Invest Ophthalmol. 1974 Oct;13(10):801–804. [PubMed] [Google Scholar]
  95. Kuppermann B. D., Petty J. G., Richman D. D., Mathews W. C., Fullerton S. C., Rickman L. S., Freeman W. R. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 May 15;115(5):575–582. doi: 10.1016/s0002-9394(14)71453-9. [DOI] [PubMed] [Google Scholar]
  96. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  97. Lange M., Klein E. B., Kornfield H., Cooper L. Z., Grieco M. H. Cytomegalovirus isolation from healthy homosexual men. JAMA. 1984 Oct 12;252(14):1908–1910. [PubMed] [Google Scholar]
  98. Laskin O. L., Cederberg D. M., Mills J., Eron L. J., Mildvan D., Spector S. A. Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med. 1987 Aug;83(2):201–207. doi: 10.1016/0002-9343(87)90685-1. [DOI] [PubMed] [Google Scholar]
  99. Lehoang P., Girard B., Robinet M., Marcel P., Zazoun L., Matheron S., Rozenbaum W., Katlama C., Morer I., Lernestedt J. O. Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1989 Jun;96(6):865–874. doi: 10.1016/s0161-6420(89)32824-7. [DOI] [PubMed] [Google Scholar]
  100. Leoung G. S., Feigal D. W., Jr, Montgomery A. B., Corkery K., Wardlaw L., Adams M., Busch D., Gordon S., Jacobson M. A., Volberding P. A. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med. 1990 Sep 20;323(12):769–775. doi: 10.1056/NEJM199009203231201. [DOI] [PubMed] [Google Scholar]
  101. Lim J. I., Enger C., Haller J. A., Campochiaro P. A., Meredith T. A., de Bustros S., Dunn J. P., Jabs D. A. Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology. 1994 Feb;101(2):264–269. doi: 10.1016/s0161-6420(13)31339-6. [DOI] [PubMed] [Google Scholar]
  102. Lipson B. K., Freeman W. R., Beniz J., Goldbaum M. H., Hesselink J. R., Weinreb R. N., Sadun A. A. Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol. 1989 May 15;107(5):523–527. doi: 10.1016/0002-9394(89)90498-4. [DOI] [PubMed] [Google Scholar]
  103. Lowder C. Y., Meisler D. M., McMahon J. T., Longworth D. L., Rutherford I. Microsporidia infection of the cornea in a man seropositive for human immunodeficiency virus. Am J Ophthalmol. 1990 Feb 15;109(2):242–244. doi: 10.1016/s0002-9394(14)76005-2. [DOI] [PubMed] [Google Scholar]
  104. Luft B. J., Hafner R., Korzun A. H., Leport C., Antoniskis D., Bosler E. M., Bourland D. D., 3rd, Uttamchandani R., Fuhrer J., Jacobson J. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med. 1993 Sep 30;329(14):995–1000. doi: 10.1056/NEJM199309303291403. [DOI] [PubMed] [Google Scholar]
  105. Macher A., Rodrigues M. M., Kaplan W., Pistole M. C., McKittrick A., Lawrinson W. E., Reichert C. M. Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome. Ophthalmology. 1985 Aug;92(8):1159–1164. doi: 10.1016/s0161-6420(85)33921-0. [DOI] [PubMed] [Google Scholar]
  106. Mansour A. M. Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J Clin Neuroophthalmol. 1990 Sep;10(3):167–174. [PubMed] [Google Scholar]
  107. Margolis T. P., Lowder C. Y., Holland G. N., Spaide R. F., Logan A. G., Weissman S. S., Irvine A. R., Josephberg R., Meisler D. M., O'Donnell J. J. Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991 Aug 15;112(2):119–131. doi: 10.1016/s0002-9394(14)76690-5. [DOI] [PubMed] [Google Scholar]
  108. Masur H., Michelis M. A., Greene J. B., Onorato I., Stouwe R. A., Holzman R. S., Wormser G., Brettman L., Lange M., Murray H. W. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981 Dec 10;305(24):1431–1438. doi: 10.1056/NEJM198112103052402. [DOI] [PubMed] [Google Scholar]
  109. Matzkin D. C., Slamovits T. L., Rosenbaum P. S. Simultaneous intraocular and orbital non-Hodgkin lymphoma in the acquired immune deficiency syndrome. Ophthalmology. 1994 May;101(5):850–855. doi: 10.1016/s0161-6420(94)31248-6. [DOI] [PubMed] [Google Scholar]
  110. McArthur J. C. Neurologic manifestations of AIDS. Medicine (Baltimore) 1987 Nov;66(6):407–437. doi: 10.1097/00005792-198711000-00001. [DOI] [PubMed] [Google Scholar]
  111. McDonnell P. J., McDonnell J. M., Brown R. H., Green W. R. Ocular involvement in patients with fungal infections. Ophthalmology. 1985 May;92(5):706–709. doi: 10.1016/s0161-6420(85)33989-1. [DOI] [PubMed] [Google Scholar]
  112. McLeish W. M., Pulido J. S., Holland S., Culbertson W. W., Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology. 1990 Feb;97(2):196–203. doi: 10.1016/s0161-6420(90)32605-2. [DOI] [PubMed] [Google Scholar]
  113. Montaner J. S., Lawson L. M., Gervais A., Hyland R. H., Chan C. K., Falutz J. M., Renzi P. M., MacFadden D., Rachlis A. R., Fong I. W. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study. Ann Intern Med. 1991 Jun 1;114(11):948–953. doi: 10.7326/0003-4819-114-11-948. [DOI] [PubMed] [Google Scholar]
  114. Morinelli E. N., Dugel P. U., Riffenburgh R., Rao N. A. Infectious multifocal choroiditis in patients with acquired immune deficiency syndrome. Ophthalmology. 1993 Jul;100(7):1014–1021. doi: 10.1016/s0161-6420(93)31543-5. [DOI] [PubMed] [Google Scholar]
  115. Muñoz A., Wang M. C., Bass S., Taylor J. M., Kingsley L. A., Chmiel J. S., Polk B. F. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. Am J Epidemiol. 1989 Sep;130(3):530–539. doi: 10.1093/oxfordjournals.aje.a115367. [DOI] [PubMed] [Google Scholar]
  116. Newsome D. A., Green W. R., Miller E. D., Kiessling L. A., Morgan B., Jabs D. A., Polk B. F. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol. 1984 Nov;98(5):590–601. doi: 10.1016/0002-9394(84)90245-9. [DOI] [PubMed] [Google Scholar]
  117. Nguyen N., Rimmer S., Katz B. Slowed saccades in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1989 Apr 15;107(4):356–360. doi: 10.1016/0002-9394(89)90658-2. [DOI] [PubMed] [Google Scholar]
  118. Northfelt D. W., Clement M. J., Safrin S. Extrapulmonary pneumocystosis: clinical features in human immunodeficiency virus infection. Medicine (Baltimore) 1990 Nov;69(6):392–398. [PubMed] [Google Scholar]
  119. OKUN E., BUTLER W. T. OPHTHALMOLOGIC COMPLICATIONS OF CRYPTOCOCCAL MENINGITIS. Arch Ophthalmol. 1964 Jan;71:52–57. doi: 10.1001/archopht.1964.00970010068009. [DOI] [PubMed] [Google Scholar]
  120. Orellana J., Teich S. A., Friedman A. H., Lerebours F., Winterkorn J., Mildvan D. Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). Ophthalmology. 1987 Jul;94(7):831–838. doi: 10.1016/s0161-6420(87)33536-5. [DOI] [PubMed] [Google Scholar]
  121. Orellana J., Teich S. A., Lieberman R. M., Restrepo S., Peairs R. Treatment of retinal detachments in patients with the acquired immune deficiency syndrome. Ophthalmology. 1991 Jun;98(6):939–943. doi: 10.1016/s0161-6420(91)32217-6. [DOI] [PubMed] [Google Scholar]
  122. Palestine A. G., Frishberg B. Macular edema in acquired immunodeficiency syndrome-related microvasculopathy. Am J Ophthalmol. 1991 Jun 15;111(6):770–771. doi: 10.1016/s0002-9394(14)76788-1. [DOI] [PubMed] [Google Scholar]
  123. Palestine A. G., Polis M. A., De Smet M. D., Baird B. F., Falloon J., Kovacs J. A., Davey R. T., Zurlo J. J., Zunich K. M., Davis M. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991 Nov 1;115(9):665–673. doi: 10.7326/0003-4819-115-9-665. [DOI] [PubMed] [Google Scholar]
  124. Palestine A. G., Rodrigues M. M., Macher A. M., Chan C. C., Lane H. C., Fauci A. S., Masur H., Longo D., Reichert C. M., Steis R. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984 Sep;91(9):1092–1099. doi: 10.1016/s0161-6420(84)34201-4. [DOI] [PubMed] [Google Scholar]
  125. Park K. L., Goins K. M. Hodgkin's lymphoma of the orbit associated with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 Jul 15;116(1):111–112. doi: 10.1016/s0002-9394(14)71760-x. [DOI] [PubMed] [Google Scholar]
  126. Parke D. W., 2nd, Font R. L. Diffuse toxoplasmic retinochoroiditis in a patient with AIDS. Arch Ophthalmol. 1986 Apr;104(4):571–575. doi: 10.1001/archopht.1986.01050160127028. [DOI] [PubMed] [Google Scholar]
  127. Parrish C. M., O'Day D. M., Hoyle T. C. Spontaneous fungal corneal ulcer as an ocular manifestation of AIDS. Am J Ophthalmol. 1987 Sep 15;104(3):302–303. doi: 10.1016/0002-9394(87)90423-5. [DOI] [PubMed] [Google Scholar]
  128. Passo M. S., Rosenbaum J. T. Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol. 1988 Jul 15;106(1):1–6. doi: 10.1016/s0002-9394(14)76378-0. [DOI] [PubMed] [Google Scholar]
  129. Pepose J. S., Holland G. N., Nestor M. S., Cochran A. J., Foos R. Y. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985 Apr;92(4):472–484. doi: 10.1016/s0161-6420(85)34008-3. [DOI] [PubMed] [Google Scholar]
  130. Pepose J. S., Newman C., Bach M. C., Quinn T. C., Ambinder R. F., Holland G. N., Hodstrom P. S., Frey H. M., Foos R. Y. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology. 1987 Apr;94(4):414–424. doi: 10.1016/s0161-6420(87)33455-4. [DOI] [PubMed] [Google Scholar]
  131. Pertel P., Hirschtick R., Phair J., Chmiel J., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5(11):1069–1074. [PubMed] [Google Scholar]
  132. Polis M. A., deSmet M. D., Baird B. F., Mellow S., Falloon J., Davey R. T., Jr, Kovacs J. A., Palestine A. G., Nussenblatt R. B., Masur H. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med. 1993 Feb;94(2):175–180. doi: 10.1016/0002-9343(93)90180-w. [DOI] [PubMed] [Google Scholar]
  133. Pomerantz R. J., Kuritzkes D. R., de la Monte S. M., Rota T. R., Baker A. S., Albert D., Bor D. H., Feldman E. L., Schooley R. T., Hirsch M. S. Infection of the retina by human immunodeficiency virus type I. N Engl J Med. 1987 Dec 24;317(26):1643–1647. doi: 10.1056/NEJM198712243172607. [DOI] [PubMed] [Google Scholar]
  134. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Dec 3;327(23):1643–1648. doi: 10.1056/NEJM199212033272306. [DOI] [PubMed] [Google Scholar]
  135. Quiceno J. I., Capparelli E., Sadun A. A., Munguia D., Grant I., Listhaus A., Crapotta J., Lambert B., Freeman W. R. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):8–13. doi: 10.1016/s0002-9394(14)75745-9. [DOI] [PubMed] [Google Scholar]
  136. Rao N. A., Zimmerman P. L., Boyer D., Biswas J., Causey D., Beniz J., Nichols P. W. A clinical, histopathologic, and electron microscopic study of Pneumocystis carinii choroiditis. Am J Ophthalmol. 1989 Mar 15;107(3):218–228. doi: 10.1016/0002-9394(89)90303-6. [DOI] [PubMed] [Google Scholar]
  137. Regillo C. D., Vander J. F., Duker J. S., Fischer D. H., Belmont J. B., Kleiner R. Repair of retinitis-related retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):21–27. doi: 10.1016/s0002-9394(14)75747-2. [DOI] [PubMed] [Google Scholar]
  138. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  139. Salmon D., Lacassin F., Harzic M., Leport C., Perronne C., Bricaire F., Brun-Vezinet F., Vilde J. L. Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol. 1990 Nov;32(3):160–163. doi: 10.1002/jmv.1890320306. [DOI] [PubMed] [Google Scholar]
  140. Sanborn G. E., Anand R., Torti R. E., Nightingale S. D., Cal S. X., Yates B., Ashton P., Smith T. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device. Arch Ophthalmol. 1992 Feb;110(2):188–195. doi: 10.1001/archopht.1992.01080140044023. [DOI] [PubMed] [Google Scholar]
  141. Sandor E. V., Millman A., Croxson T. S., Mildvan D. Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am J Ophthalmol. 1986 Feb 15;101(2):153–155. doi: 10.1016/0002-9394(86)90585-4. [DOI] [PubMed] [Google Scholar]
  142. Santos C., Parker J., Dawson C., Ostler B. Bilateral fungal corneal ulcers in a patient with AIDS-related complex. Am J Ophthalmol. 1986 Jul 15;102(1):118–119. doi: 10.1016/0002-9394(86)90221-7. [DOI] [PubMed] [Google Scholar]
  143. Schneider M. M., Hoepelman A. I., Eeftinck Schattenkerk J. K., Nielsen T. L., van der Graaf Y., Frissen J. P., van der Ende I. M., Kolsters A. F., Borleffs J. C. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med. 1992 Dec 24;327(26):1836–1841. doi: 10.1056/NEJM199212243272603. [DOI] [PubMed] [Google Scholar]
  144. Schnittman S. M., Lane H. C., Higgins S. E., Folks T., Fauci A. S. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science. 1986 Sep 5;233(4768):1084–1086. doi: 10.1126/science.3016902. [DOI] [PubMed] [Google Scholar]
  145. Schuman J. S., Friedman A. H. Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii. Trans Ophthalmol Soc U K. 1983;103(Pt 2):177–190. [PubMed] [Google Scholar]
  146. Schuman J. S., Orellana J., Friedman A. H., Teich S. A. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol. 1987 May-Jun;31(6):384–410. doi: 10.1016/0039-6257(87)90031-2. [DOI] [PubMed] [Google Scholar]
  147. Sellitti T. P., Huang A. J., Schiffman J., Davis J. L. Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol. 1993 Sep 15;116(3):297–301. doi: 10.1016/s0002-9394(14)71346-7. [DOI] [PubMed] [Google Scholar]
  148. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  149. Shami M. J., Freeman W., Friedberg D., Siderides E., Listhaus A., Ai E. A multicenter study of Pneumocystis choroidopathy. Am J Ophthalmol. 1991 Jul 15;112(1):15–22. doi: 10.1016/s0002-9394(14)76206-3. [DOI] [PubMed] [Google Scholar]
  150. Shaw G. M., Harper M. E., Hahn B. H., Epstein L. G., Gajdusek D. C., Price R. W., Navia B. A., Petito C. K., O'Hara C. J., Groopman J. E. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. doi: 10.1126/science.2981429. [DOI] [PubMed] [Google Scholar]
  151. Shuler J. D., Holland G. N., Miles S. A., Miller B. J., Grossman I. Kaposi sarcoma of the conjunctiva and eyelids associated with the acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jun;107(6):858–862. doi: 10.1001/archopht.1989.01070010880035. [DOI] [PubMed] [Google Scholar]
  152. Sidikaro Y., Silver L., Holland G. N., Kreiger A. E. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology. 1991 Feb;98(2):129–135. [PubMed] [Google Scholar]
  153. Slavin M. L., Mallin J. E., Jacob H. S. Isolated homonymous hemianopsia in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1989 Aug 15;108(2):198–200. doi: 10.1016/0002-9394(89)90023-8. [DOI] [PubMed] [Google Scholar]
  154. Spector S. A., Weingeist T., Pollard R. B., Dieterich D. T., Samo T., Benson C. A., Busch D. F., Freeman W. R., Montague P., Kaplan H. J. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis. 1993 Sep;168(3):557–563. doi: 10.1093/infdis/168.3.557. [DOI] [PubMed] [Google Scholar]
  155. Stanton C. A., Sloan B., 3rd, Slusher M. M., Greven C. M. Acquired immunodeficiency syndrome-related primary intraocular lymphoma. Arch Ophthalmol. 1992 Nov;110(11):1614–1617. doi: 10.1001/archopht.1992.01080230114034. [DOI] [PubMed] [Google Scholar]
  156. Stoumbos V. D., Klein M. L. Syphilitic retinitis in a patient with acquired immunodeficiency syndrome-related complex. Am J Ophthalmol. 1987 Jan 15;103(1):103–104. doi: 10.1016/s0002-9394(14)74179-0. [DOI] [PubMed] [Google Scholar]
  157. Teich S. A. Conjunctival vascular changes in AIDS and AIDS-related complex. Am J Ophthalmol. 1987 Mar 15;103(3 Pt 1):332–333. [PubMed] [Google Scholar]
  158. Tenhula W. N., Xu S. Z., Madigan M. C., Heller K., Freeman W. R., Sadun A. A. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):14–20. doi: 10.1016/s0002-9394(14)75746-0. [DOI] [PubMed] [Google Scholar]
  159. Ussery F. M., 3rd, Gibson S. R., Conklin R. H., Piot D. F., Stool E. W., Conklin A. J. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology. 1988 May;95(5):640–648. doi: 10.1016/s0161-6420(88)33147-7. [DOI] [PubMed] [Google Scholar]
  160. Walmsley S. L., Chew E., Read S. E., Vellend H., Salit I., Rachlis A., Fanning M. M. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet). J Infect Dis. 1988 Mar;157(3):569–572. doi: 10.1093/infdis/157.3.569. [DOI] [PubMed] [Google Scholar]
  161. Whitcup S. M., Fenton R. M., Pluda J. M., De Smet M. D., Nussenblatt R. B., Chan C. C. Pneumocystis carinii and Mycobacterium avium-intracellulare infection of the choroid. Retina. 1992;12(4):331–335. doi: 10.1097/00006982-199212040-00006. [DOI] [PubMed] [Google Scholar]
  162. Winward K. E., Hamed L. M., Glaser J. S. The spectrum of optic nerve disease in human immunodeficiency virus infection. Am J Ophthalmol. 1989 Apr 15;107(4):373–380. doi: 10.1016/0002-9394(89)90660-0. [DOI] [PubMed] [Google Scholar]
  163. Zuger A., Louie E., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986 Feb;104(2):234–240. doi: 10.7326/0003-4819-104-2-234. [DOI] [PubMed] [Google Scholar]
  164. Zurlo J. J., O'Neill D., Polis M. A., Manischewitz J., Yarchoan R., Baseler M., Lane H. C., Masur H. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med. 1993 Jan 1;118(1):12–17. doi: 10.7326/0003-4819-118-1-199301010-00003. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES